Fig. 2From: Analysis of stromal PDGFR-β and α-SMA expression and their clinical relevance in brain metastases of breast cancer patientsComparison of PDGFR-β and α-SMA expression in the same case. In the same BM case, the expression of PDGFR-β (A) at score 3 and α-SMA (B) at score 2 was compared. Comparison of the two markers in 50 BM cases, showed a moderate level of agreement (kappa value = 0.684). The expression of PDGFR-β (C) at score 1 and α-SMA (D) at score 3 in the same primary BC was compared. The expression of the two markers showed no agreement in 18 primary BC samples (kappa value = 0.091)Back to article page